People in their 50s are returning bowel cancer screening kits at lower rates than other age groups, according to annual figures released by NHS England. The data, which covers the period from April 2024 to March 2025, has prompted a renewed push from health officials to raise participation among this demographic.
Participation Rates Among Those in Their 50s
Of all the age groups eligible for bowel cancer screening, 54-year-olds showed some of the lowest engagement. According to NHS England's annual bowel screening figures, just 56.2% of people aged 54 completed the screening process during the 2024–25 reporting year. That means nearly four in ten individuals in that age bracket did not return their kits during the period measured.
The figures highlight a persistent gap in uptake among younger eligible adults — those who have only recently entered the screening age window — compared with older cohorts who may have had more exposure to the programme over time.
Scale of Detection Through the Programme
The same dataset underscores the volume of diagnoses the screening programme is generating. Across the year, the programme was identifying roughly 100 bowel cancers per week, a figure NHS England described as central to its case for wider participation.
Bowel cancer screening works by detecting blood in stool samples using a home test kit, which is then analysed to determine whether further investigation is warranted. When abnormalities are caught at an early stage, treatment outcomes are generally more favourable — a point reflected in the programme's continued expansion to younger age groups in recent years.
Why the 50s Age Group Matters
The NHS lowered the eligible age for bowel cancer screening from 60 to 50 in a phased rollout, meaning many people in their early-to-mid 50s are encountering the programme for the first time. Health officials have suggested that unfamiliarity with the process, or uncertainty about how to complete the kit correctly, may contribute to lower return rates in this group.
The test itself is conducted at home and involves collecting small stool samples over several days before returning the kit by post. No clinic visit is required for the initial screening stage, which health authorities have long cited as one of the programme's practical advantages.
Broader Context
Bowel cancer is among the most commonly diagnosed cancers in England. Early detection through population-level screening has been associated with identifying disease at stages where intervention is more likely to be effective, according to established public health evidence.
The NHS England figures serve as a reminder that screening programmes depend heavily on public participation to function as intended. A programme capable of finding 100 cancers per week can only do so if eligible individuals complete and return their kits — a dynamic that makes uptake data among lower-participating groups a continuing focus for health planners.
The annual figures covering April 2024 to March 2025 represent the most recent complete reporting cycle available, and NHS England has indicated that encouraging participation among people in their 50s remains a priority heading into the next period.